3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Urinary Bladder Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Urinary Tract Infections
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Stem Cell Transplant Complications
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Prostatic Hyperplasia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Neutropenia
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Mycoses
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Intraocular Lymphoma
1
Infections
1
Interventions
Tablets
1
Levofloxacin
1
Fluconazole
1
Acyclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Stem Cell Transplant Complications
×
Levofloxacin
×
Clear all
NCT03159845
2020-01-07
ZENITH
Azienda Ospedaliero, Universitaria Pisana
Phase 2
Completed
20 enrolled